ClinicalTrials.gov record
Terminated Phase 1Phase 2 Interventional Results available

A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL

ClinicalTrials.gov ID: NCT01483690

Public ClinicalTrials.gov record NCT01483690. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 5:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT01483690
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Therapeutic Advances in Childhood Leukemia Consortium
Other
Enrollment
23 participants

Conditions and interventions

Interventions

  • Decitabine Drug
  • Dexamethasone Drug
  • Methotrexate Drug
  • Mitoxantrone Drug
  • Pegaspargase Drug
  • Vincristine Drug
  • Vorinostat Drug

Drug

Eligibility (public fields only)

Age range
1 Year to 21 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2011
Primary completion
Jul 30, 2015
Completion
Jul 30, 2015
Last update posted
Oct 26, 2020

2011 – 2015

United States locations

U.S. sites
25
U.S. states
19
U.S. cities
23
Facility City State ZIP Site status
Childrens Hospital Los Angeles Los Angeles California 90027
CHOC Orange California
UCSF School of Medicine San Francisco California 94143-0106
The Children's Hospital, University of Colorado Aurora Colorado 80045
Children's National Medical Center Washington D.C. District of Columbia
University of Miami Cancer Center Miami Florida 33136
Children's Healthcare of Atlanta, Emory University Atlanta Georgia
Lurie Children's Hospital Chicago Illinois
Johns Hopkins University Baltimore Maryland
Dana Farber Boston Massachusetts
C.S. Mott Children's Hospital Ann Arbor Michigan 48109-0914
Childrens Hospital & Clinics of Minnesota Minneapolis Minnesota 55404-4597
University of Minnesota Children's Hospital Minneapolis Minnesota
Children's Mercy Hospitals and Clinics Kansas City Missouri 64108
New York University Medical Center New York New York 10016
Children's Hospital New York-Presbyterian New York New York 10032
Levine Children's Hospital at Carolinas Medical Center Charlotte North Carolina 28203
Nationwide Childrens Hospital Columbus Ohio
Oregon Health and Science University Portland Oregon
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
St. Jude Memphis Tennessee 38105-3678
Vanderbilt Children's Hospital Nashville Tennessee
University of Texas at Southwestern Dallas Texas
Cook Children's Medical Center Fort Worth Texas 76104
Seattle Children's Hospital Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01483690, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 26, 2020 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01483690 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →